Integrated In Silico and In Vitro Investigation of Chromene Derivatives as Potential Antidiabetic Agents in 3T3-L1 Cells.
Type 2 diabetes mellitus is characterized by a progressive decline in insulin sensitivity and represents an important therapeutic target for improving glucose homeostasis. Chromen-derived compounds have attracted interest as potential antidiabetic agents because of their diverse pharmacological activities. Drug-likenes...